InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARVINAS, INC.

ARVN Clue Score64
United States Fiscal year ends December CIK 0001655759 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
Briggs Morrison
6 Mar 2026
Director
Buy
20,000
$13.40
$268.07K
Briggs Morrison
22 Sep 2025
Director
Buy
30,000
$7.57
$227.01K
Liam Ratcliffe
18 Dec 2020
Director
Buy indirect
142,857
$70.00
$10.00M
Edward Moore Kennedy Jr.
9 Nov 2020
Director
Buy
8,333
$23.99
$199.91K
Timothy M Shannon
17 Jun 2020
Director
Buy
2,000
$30.26
$60.52K
Timothy M Shannon
2 Jun 2020
Director
Buy
3,000
$32.30
$96.90K
Briggs Morrison
24 Mar 2020
Director
Buy
2,500
$38.18
$95.45K
Timothy M Shannon
20 Mar 2020
Director
Buy
2,500
$40.00
$100.00K
Liam Ratcliffe
12 Nov 2019
Director
Buy indirect
680,000
$22.00
$14.96M
Ian Taylor
29 Mar 2019
Chief Scientific Officer
Buy
1,000
$14.66
$14.66K
Timothy M Shannon
28 Mar 2019
Director
Buy
3,500
$14.69
$51.41K
James E Flynn
1 Oct 2018
10% owner
Buy indirect
104,166
$16.00
$1.67M
James E Flynn
1 Oct 2018
10% owner
Buy indirect
104,167
$16.00
$1.67M
James E Flynn
1 Oct 2018
10% owner
Buy indirect
104,167
$16.00
$1.67M
Ra Capital Management, L.p.
1 Oct 2018
Former 10% Owner
Buy indirect
1,000,000
$16.00
$16.00M
Jakob Loven
1 Oct 2018
Director
Buy indirect
312,500
$16.00
$5.00M
Sean A Cassidy
1 Oct 2018
Chief Financial Officer
Buy
1,600
$16.00
$25.60K
Bradley Albert Margus
1 Oct 2018
Director
Buy
40,000
$16.00
$640.00K
Liam Ratcliffe
1 Oct 2018
Director
Buy indirect
375,000
$16.00
$6.00M
Liam Ratcliffe
1 Oct 2018
Director
Buy indirect
625,000
$16.00
$10.00M
John G Houston
1 Oct 2018
President and CEO
Buy
30,000
$16.00
$480.00K
Edward Moore Kennedy Jr.
1 Oct 2018
Director
Buy
21,000
$16.00
$336.00K
Timothy M Shannon
1 Oct 2018
Director
Buy
4,000
$16.00
$64.00K
Show all 240 transactions →

What was left out

Form 4 filings counted 243
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 80
Sales at will 118
Transactions with no price 0
Shares from compensation/vesting 25,802,990
Sales filed before the plan box existed 81
History held since 28 Sep 2018